Association between serum uric acid and prostate cancer risk: The modifying role of CTGF genotype
Monitoring and lowering serum uric acid may help reduce prostate cancer risk in men with the <i>CTGF</i>-<i>CC</i> genotype.
Authors
- Bradley J. Willcox (ORCID: https://orcid.org/0000-0001-9890-3520)
- Kamal Masaki (ORCID: https://orcid.org/0000-0003-1170-3118)
- Timothy A. Donlon (ORCID: https://orcid.org/0000-0001-6545-6533)
- Randi Chen (ORCID: https://orcid.org/0000-0003-3747-7964)
- Brian Morris (ORCID: https://orcid.org/0000-0003-2468-3566)
- Richard Allsopp (ORCID: https://orcid.org/0000-0001-7565-5325)
Institutions
- The University of Sydney (AU)
- University of Hawaii System (US)
Publication Details
- Journal
- Journal of Clinical and Translational Research
- Published
- 2025-10-15
- DOI
- https://doi.org/10.36922/jctr025260029
- Citations
- 1
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 1.43